It appears after six years and thousands of lawsuits for transvaginal mesh injuries, the U.S. Food and Drug Administration (FDA) is proposing to reclassify the surgical mesh for pelvic organ prolapse (POP) repair to a “high-risk device.” Med Page Today, a news service for physicians, published an article titled: “FDA Wants High-Risk Label for Transvaginal … Read More